Login
Companies $AZTR
$0.63 +$0.00 (0.48%) After hours
Azitra, Inc. logo

Azitra, Inc.

azitrainc.com

What Do They Do?

Develops engineered proteins and topical live-bacteria treatments for skin diseases in patients with dermatologic conditions.

Who Are Their Customers?

Its service work is done under a joint development agreement with a research partner, and federal agencies and nonprofit research institutions provide research grants. Azitra has not established a commercial sales or distribution organization.

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Net income
▼ −7% (Loss)
vs −$2.8M in Q3 FY2025

Who Do They Compete With?

Competes with Sixera Pharma, Quoin Pharmaceuticals, Boehringer Ingelheim, Daiichi Sankyo, ResVita Bio, MatriSys, Hoth Therapeutics, Lutris Pharma, and Daewoong Pharmaceutical

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support